Correlation Between SunOpta and Clarity Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SunOpta and Clarity Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SunOpta and Clarity Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SunOpta and Clarity Pharmaceuticals, you can compare the effects of market volatilities on SunOpta and Clarity Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SunOpta with a short position of Clarity Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SunOpta and Clarity Pharmaceuticals.

Diversification Opportunities for SunOpta and Clarity Pharmaceuticals

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between SunOpta and Clarity is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding SunOpta and Clarity Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clarity Pharmaceuticals and SunOpta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SunOpta are associated (or correlated) with Clarity Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clarity Pharmaceuticals has no effect on the direction of SunOpta i.e., SunOpta and Clarity Pharmaceuticals go up and down completely randomly.

Pair Corralation between SunOpta and Clarity Pharmaceuticals

Given the investment horizon of 90 days SunOpta is expected to generate 0.3 times more return on investment than Clarity Pharmaceuticals. However, SunOpta is 3.39 times less risky than Clarity Pharmaceuticals. It trades about -0.09 of its potential returns per unit of risk. Clarity Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest  754.00  in SunOpta on November 5, 2024 and sell it today you would lose (21.00) from holding SunOpta or give up 2.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

SunOpta  vs.  Clarity Pharmaceuticals

 Performance 
       Timeline  
SunOpta 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in SunOpta are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite weak forward-looking signals, SunOpta may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Clarity Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clarity Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

SunOpta and Clarity Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SunOpta and Clarity Pharmaceuticals

The main advantage of trading using opposite SunOpta and Clarity Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SunOpta position performs unexpectedly, Clarity Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clarity Pharmaceuticals will offset losses from the drop in Clarity Pharmaceuticals' long position.
The idea behind SunOpta and Clarity Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges